NHWL071065
NHWL071065 is a CRBN-targeting IKZF1/IKZF3 molecular glues degrader. NHWL071065 selectively degrades IKZF1 and IKZF3 in lymphoma cells via the ubiquitin-proteasome pathway. NHWL071065 inhibits the proliferation of lymphoma cells. NHWL071065 downregulates proteins involved in cytoskeleton assembly, cell adhesion and immune regulation in cells, while upregulating proteins related to the type I IFN signaling pathway. NHWL071065 can be used in the research of lymphoma.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3117340-01-6
- 화학식: C31H37FN6O4
- 분자량:576.66
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
[1]|
IKZF1 |
IKZF3 |
In Vitro
NHWL071065 (Compound 26) (3 days) potently inhibits the proliferation of TMD8 cells (IC50 = 6.6 nM) and WSU-DLCL2 cells (IC50 = 2.6 nM), but shows no inhibitory activity against MKN28, PANC-1, LO2 or HUVEC cells[1].
NHWL071065 (1.25-40 nM, 0.313-5 μM; 16 h) potently and selectively degrades IKZF1 (DC50 = 1.8 nM) and IKZF3 (DC50 = 14.9 nM) in TMD8 cells, induces concentration-dependent degradation of IKZF1/IKZF3 in WSU-DLCL2 cells, and does not degrade PDE6D, SALL4 or GSPT1[1].
NHWL071065 (100 nM; 6 h) significantly downregulates IKZF1/IKZF3 and proteins involved in cytoskeleton assembly, cell adhesion and immune regulation in TMD8 cells, while upregulating proteins related to the type I interferon signaling pathway, but exerts no significant effects on GSPT1, NEK7 or CK1α[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:TMD8 lymphoma cells, WSU-DLCL2 lymphoma cells
-
Concentration:1.25, 2.5, 5, 10, 20, 40 nM (TMD8 cells, IKZF1/IKZF3); 1, 5, 10, 50 nM (WSU-DLCL2 cells, IKZF1/IKZF3); 0.313, 0.625, 1.25, 2.5, 5 μM (TMD8 cells, PDE6D/SALL4); 1, 5, 10, 50 nM (TMD8 cells, GSPT1)
-
Incubation Time:16 h
-
Result:Achieved a DC50 of 1.8 nM for IKZF1 degradation and 14.9 nM for IKZF3 degradation in TMD8 cells, with near-complete degradation at 40 nM.
Concentration-dependently degraded both IKZF1 and IKZF3 in WSU-DLCL2 cells, with significant reduction observed at 1 nM.
Did not degrade PDE6D (up to 5 μM), SALL4 (up to 2.5 μM), or GSPT1 (at concentrations that potently degrade IKZF1/3) in TMD8 cells.
Parmacokinetics
Chemical Information
-
CAS No. 3117340-01-6
-
분자량 576.66
-
화학식 C31H37FN6O4
-
SMILES
O=C(C(N1C(C)=NC2=C(C(NCC3=CC=C(CN4CCC(N5CCOCC5)CC4)C=C3F)=CC=C2)C1=O)CC6)NC6=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)